| Sonya Coolahan, | |
|
353 Fairmont Blvd, Rapid City, SD 57701-7375 | |
| (605) 719-1000 | |
| Not Available |
| Full Name | Sonya Coolahan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 353 Fairmont Blvd, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194165068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R033123 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
A study in experimental models suggests that allopregnanolone, one of many hormones produced by the placenta during pregnancy, is so essential to normal fetal brain development that when provision of that hormone decreases or stops abruptly - as occurs with premature birth - offspring are more likely to develop autism-like behaviors.
Young women with breast cancer experienced substantial financial difficulties in the wake of a breast cancer diagnosis, even if they had stable jobs with insurance benefits.
It's well-known that using a cell phone while driving can lead to motor vehicle crashes. New research - to be presented Sunday, April 29, at the Pediatric Academic Societies (PAS) annual meeting in Boston - shows that even anticipating calls or messages may distract drivers, increasing the risk of a crash.
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
› Verified 6 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
A study in experimental models suggests that allopregnanolone, one of many hormones produced by the placenta during pregnancy, is so essential to normal fetal brain development that when provision of that hormone decreases or stops abruptly - as occurs with premature birth - offspring are more likely to develop autism-like behaviors.
Young women with breast cancer experienced substantial financial difficulties in the wake of a breast cancer diagnosis, even if they had stable jobs with insurance benefits.
It's well-known that using a cell phone while driving can lead to motor vehicle crashes. New research - to be presented Sunday, April 29, at the Pediatric Academic Societies (PAS) annual meeting in Boston - shows that even anticipating calls or messages may distract drivers, increasing the risk of a crash.
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sonya Coolahan, 353 Fairmont Blvd, Atten Christie Mss, Rapid City, SD 57701-7375 Ph: () - | Sonya Coolahan, 353 Fairmont Blvd, Rapid City, SD 57701-7375 Ph: (605) 719-1000 |
News Archive
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
A study in experimental models suggests that allopregnanolone, one of many hormones produced by the placenta during pregnancy, is so essential to normal fetal brain development that when provision of that hormone decreases or stops abruptly - as occurs with premature birth - offspring are more likely to develop autism-like behaviors.
Young women with breast cancer experienced substantial financial difficulties in the wake of a breast cancer diagnosis, even if they had stable jobs with insurance benefits.
It's well-known that using a cell phone while driving can lead to motor vehicle crashes. New research - to be presented Sunday, April 29, at the Pediatric Academic Societies (PAS) annual meeting in Boston - shows that even anticipating calls or messages may distract drivers, increasing the risk of a crash.
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
› Verified 6 days ago
Maria Sargent, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-1000 | |
Kayla Sayer, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 640 Flormann St, Rapid City, SD 57701 Phone: 605-755-3300 | |
Jennifer Ann Erdman, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 636 Saint Anne St, Rapid City, SD 57701 Phone: 605-348-8000 Fax: 605-348-4315 | |
Natasha Gray, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2805 5th St, Rapid City, SD 57701 Phone: 605-755-5700 | |
Morgan Folchert, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1760 Centre St Ste 2, Rapid City, SD 57703 Phone: 308-249-2912 | |
Paulette A Kirby, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 811 Columbus St, Rapid City, SD 57701 Phone: 605-343-3007 | |
Rebecca Bierle, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4150 5th St, Rapid City, SD 57701 Phone: 605-755-4300 |